Literature DB >> 19373562

Host and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders.

Suman Jayadev1, Gwenn A Garden.   

Abstract

The human immunodeficiency virus (HIV) invades the central nervous system early in the course of infection and establishes a protected viral reservoir. However, neurocognitive consequences of HIV infection, known collectively as HIV-associated neurocognitive disorders (HAND), develop in only a small portion of infected patients. The precise mechanisms of pathogenesis involved in HIV-induced central nervous system injury are still not completely understood. In particular, most theories of HAND pathogenesis cannot account for either the selective vulnerability of specific neuronal populations to HIV-induced neurodegeneration or why only a subset of patients develop clinically detectable nervous system disease. Epidemiological and virological studies have identified a variety of host and viral factors that are associated with increased risk of developing HAND. Some host factors that predispose HIV-infected patients to HAND overlap with those associated with Alzheimer's disease (AD), suggesting the possibility that common pathogenic mechanisms may participate in both diseases. Here, we will review reports of host and viral factors associated with HAND and place these studies in the context of the data employed to support current theories regarding the molecular and cellular mechanisms that lead to HIV-induced neurodegeneration with additional focus on mechanisms common to AD pathogenesis.

Entities:  

Mesh:

Year:  2009        PMID: 19373562      PMCID: PMC2775061          DOI: 10.1007/s11481-009-9154-6

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  167 in total

1.  Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathology.

Authors:  S C Piller; P Jans; P W Gage; D A Jans
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

2.  Elevated cerebrospinal fluid glutamate in patients with HIV-related dementia.

Authors:  D Gurwitz; Y Kloog
Journal:  JAMA       Date:  1997-06-25       Impact factor: 56.272

3.  HIV dementia and apolipoprotein E.

Authors:  O Dunlop; A K Goplen; K Liestøl; B Myrvang; H Rootwelt; B Christophersen; E A Kvittingen; J Maehlen
Journal:  Acta Neurol Scand       Date:  1997-05       Impact factor: 3.209

4.  Apoptosis induced by HIV-1 infection of the central nervous system.

Authors:  B Shi; U De Girolami; J He; S Wang; A Lorenzo; J Busciglio; D Gabuzda
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

5.  Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center.

Authors:  E Masliah; R K Heaton; T D Marcotte; R J Ellis; C A Wiley; M Mallory; C L Achim; J A McCutchan; J A Nelson; J H Atkinson; I Grant
Journal:  Ann Neurol       Date:  1997-12       Impact factor: 10.422

6.  Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC)

Authors:  C Winkler; W Modi; M W Smith; G W Nelson; X Wu; M Carrington; M Dean; T Honjo; K Tashiro; D Yabe; S Buchbinder; E Vittinghoff; J J Goedert; T R O'Brien; L P Jacobson; R Detels; S Donfield; A Willoughby; E Gomperts; D Vlahov; J Phair; S J O'Brien
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

7.  Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.

Authors:  M Samson; F Libert; B J Doranz; J Rucker; C Liesnard; C M Farber; S Saragosti; C Lapoumeroulie; J Cognaux; C Forceille; G Muyldermans; C Verhofstede; G Burtonboy; M Georges; T Imai; S Rana; Y Yi; R J Smyth; R G Collman; R W Doms; G Vassart; M Parmentier
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

8.  Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry.

Authors:  S L Wesselingh; K Takahashi; J D Glass; J C McArthur; J W Griffin; D E Griffin
Journal:  J Neuroimmunol       Date:  1997-04       Impact factor: 3.478

Review 9.  Host factors and the pathogenesis of HIV-induced disease.

Authors:  A S Fauci
Journal:  Nature       Date:  1996-12-12       Impact factor: 49.962

10.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

View more
  16 in total

1.  Synapse loss induced by interleukin-1β requires pre- and post-synaptic mechanisms.

Authors:  Anjuli Mishra; Hee Jung Kim; Angela H Shin; Stanley A Thayer
Journal:  J Neuroimmune Pharmacol       Date:  2012-02-05       Impact factor: 4.147

2.  The aging of human-immunodeficiency-virus-associated neurocognitive disorders.

Authors:  Tsuneya Ikezu
Journal:  J Neuroimmune Pharmacol       Date:  2009-05-05       Impact factor: 4.147

3.  Basal ganglia shrinkage without remarkable hippocampal atrophy in chronic aviremic HIV-positive patients.

Authors:  Tamara Tesic; Jasmina Boban; Mladen Bjelan; Aleksandar Todorovic; Dusko Kozic; Snezana Brkic
Journal:  J Neurovirol       Date:  2018-04-23       Impact factor: 2.643

4.  HIV clades B and C are associated with reduced brain volumetrics.

Authors:  Mario Ortega; Jodi M Heaps; John Joska; Florin Vaida; Soraya Seedat; Dan J Stein; Robert Paul; Beau M Ances
Journal:  J Neurovirol       Date:  2013-10       Impact factor: 2.643

5.  Antioxidant sestrin-2 redistribution to neuronal soma in human immunodeficiency virus-associated neurocognitive disorders.

Authors:  Virawudh Soontornniyomkij; Benchawanna Soontornniyomkij; David J Moore; Ben Gouaux; Eliezer Masliah; Spencer Tung; Harry V Vinters; Igor Grant; Cristian L Achim
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-27       Impact factor: 4.147

6.  Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers.

Authors:  Virawudh Soontornniyomkij; David J Moore; Ben Gouaux; Benchawanna Soontornniyomkij; Erick T Tatro; Anya Umlauf; Eliezer Masliah; Andrew J Levine; Elyse J Singer; Harry V Vinters; Benjamin B Gelman; Susan Morgello; Mariana Cherner; Igor Grant; Cristian L Achim
Journal:  AIDS       Date:  2012-11-28       Impact factor: 4.177

7.  Increased cortical expression of FK506 binding protein-51 in HIV-associated neurocognitive disorders.

Authors:  Virawudh Soontornniyomkij; Ian P Everall; David J Moore; Ben Gouaux; Erick T Tatro; Vadim Gospodarev; Eliezer Masliah; Nicole S Yin; Harry V Vinters; Cristian L Achim
Journal:  J Neurovirol       Date:  2012-01-11       Impact factor: 2.643

8.  HIV-infected microglia mediate cathepsin B-induced neurotoxicity.

Authors:  Frances Zenón; Yisel Cantres-Rosario; Radhika Adiga; Mariangeline Gonzalez; Eillen Rodriguez-Franco; Dianne Langford; Loyda M Melendez
Journal:  J Neurovirol       Date:  2015-06-20       Impact factor: 2.643

9.  HIV-1 Tat-mediated microglial inflammation involves a novel miRNA-34a-NLRC5-NFκB signaling axis.

Authors:  Palsamy Periyasamy; Annadurai Thangaraj; Venkata Sunil Bendi; Shilpa Buch
Journal:  Brain Behav Immun       Date:  2019-03-11       Impact factor: 7.217

10.  Sleep, Fatigue, and Problems With Cognitive Function in Adults Living With HIV.

Authors:  Eeeseung Byun; Caryl L Gay; Kathryn A Lee
Journal:  J Assoc Nurses AIDS Care       Date:  2015-10-13       Impact factor: 1.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.